# Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation

> **NCT04877067** · PHASE3 · COMPLETED · sponsor: **Ankara Universitesi Teknokent** · enrollment: 18 (actual)

## Conditions studied

- Methanol Poisoning
- Toxic Optic Neuropathy
- Stem Cell Tyrosine Kinase 1 Y842X
- Magnetic Field Exposure

## Interventions

- **BIOLOGICAL:** Wharton jelly derived mesenchymal stem cell
- **DEVICE:** Repetitive electromagnetic stimulation

## Key facts

- **NCT ID:** NCT04877067
- **Lead sponsor:** Ankara Universitesi Teknokent
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04877067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04877067, "Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04877067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*